Tyche Industries Ltd Stock Price Today (NSE: TYCHE)
Fundamental Score
Tyche Industries Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Tyche Industries Ltd share price today is ₹124.10, down 1.51% on NSE/BSE as of 7 August 2026. Tyche Industries Ltd (TYCHE) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹134.89 (Cr). The 52-week high for TYCHE share price is ₹148.00 and the 52-week low is ₹99.00. At a P/E ratio of 19.44x, TYCHE is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 5.01% and a debt-to-equity ratio of 0.00.
Tyche Industries Ltd Share Price Chart — NSE/BSE Historical Performance
Tyche Industries Ltd share price chart: -4.09% return over the past month. 52-week high ₹148.00, 52-week low ₹99.00.
Tyche Industries Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹127.80 | ₹129.95 | ₹123.15 | ₹126.00 | 21.59K (Cr) | |
| ₹125.05 | ₹127.00 | ₹122.30 | ₹125.05 | 974.00 (Cr) | |
| ₹120.60 | ₹127.00 | ₹120.60 | ₹126.10 | 16.89K (Cr) | |
| ₹120.15 | ₹125.80 | ₹120.15 | ₹123.30 | 389.00 (Cr) | |
| ₹122.15 | ₹124.95 | ₹120.50 | ₹122.00 | 1.01K (Cr) | |
| ₹125.65 | ₹127.85 | ₹121.00 | ₹122.15 | 8.87K (Cr) | |
| ₹127.95 | ₹127.95 | ₹124.10 | ₹125.65 | 1.51K (Cr) | |
| ₹126.90 | ₹128.45 | ₹122.30 | ₹126.00 | 1.79K (Cr) | |
| ₹128.70 | ₹131.85 | ₹125.15 | ₹131.50 | 2.60K (Cr) | |
| ₹128.60 | ₹129.10 | ₹126.25 | ₹128.70 | 420.00 (Cr) |
Tyche Industries Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹120.15 | ₹129.95 | ₹120.15 | ₹126.00 | +4.87% | |
| ₹127.80 | ₹132.50 | ₹120.00 | ₹122.00 | -4.54% | |
| ₹142.65 | ₹142.65 | ₹121.20 | ₹128.90 | -9.64% | |
| ₹119.20 | ₹148.00 | ₹119.20 | ₹136.80 | +14.77% | |
| ₹100.01 | ₹134.49 | ₹100.01 | ₹122.92 | +22.91% | |
| ₹114.25 | ₹115.95 | ₹99.00 | ₹99.80 | -12.65% | |
| ₹103.40 | ₹140.05 | ₹103.30 | ₹114.25 | +10.49% | |
| ₹115.90 | ₹123.00 | ₹100.00 | ₹105.40 | -9.06% | |
| ₹120.90 | ₹123.80 | ₹105.20 | ₹115.90 | -4.14% | |
| ₹134.00 | ₹135.60 | ₹116.85 | ₹121.25 | -9.51% | |
| ₹136.60 | ₹145.45 | ₹130.00 | ₹132.20 | -3.22% | |
| ₹136.20 | ₹146.00 | ₹132.15 | ₹139.95 | +2.75% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Tyche Industries Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Tyche Industries Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of TYCHE across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Strong Operating Margins (16.33%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 19.44 vs Industry: 34.89)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (22.34%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (30.96%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (61.97%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Below-Average Return on Equity (5.01%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (6.83%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Limited Growth History (-7.28% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-19.65% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-19.65% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Tyche Industries Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Tyche Industries Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Tyche Industries LtdTyche Industrie...Selected✓ TYCHE • 532384 | 45.1/100 | ₹124.10₹124 | ₹134.89₹134.89 | 19.44Average 19.4 Average | 5.01%Poor 5.01% Poor | 6.83%Poor 6.83% Poor | 0.00Excellent 0.0 Excellent | -19.65%Poor -19.65% Poor | -7.28%Poor -7.28% Poor | 2.28% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1990.50₹1991 | ₹468821.49₹468821.49 | 37.73Average 37.7 Average | 15.95%Good 15.95% Good | 20.53%Excellent 20.53% Excellent | 0.06Excellent 0.1 Excellent | 16.75%Excellent 16.75% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 56.3/100 | ₹8056.00₹8056 | ₹193163.97₹193163.97 | 73.64Average 73.6 Average | 16.53%Good 16.53% Good | 21.96%Excellent 21.96% Excellent | 0.00Excellent 0.0 Excellent | 5.71%Good 5.71% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹5122.80₹5123 | ₹169902.02₹169902.02 | 77.52Average 77.5 Average | 27.43%Excellent 27.43% Excellent | 15.19%Good 15.19% Good | 1.79Average 1.8 Average | 12.07%Good 12.07% Good | 11.80%Good 11.80% Good | 0.76% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 40.2/100 | ₹1473.20₹1473 | ₹116131.81₹116131.81 | 30.51Average 30.5 Average | 11.60%Average 11.60% Average | 15.49%Good 15.49% Good | 0.02Excellent 0.0 Excellent | 9.94%Good 9.94% Good | 8.01%Good 8.01% Good | 0.90% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1078.30₹1078 | ₹115375.77₹115375.77 | 21.26Average 21.3 Average | 21.25%Excellent 21.25% Excellent | 21.14%Excellent 21.14% Excellent | 0.46Excellent 0.5 Excellent | 18.77%Excellent 18.77% Excellent | 12.45%Good 12.45% Good | 0.09% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 83.4/100 | ₹2415.00₹2415 | ₹113976.53₹113976.53 | 20.04Average 20.0 Average | 28.68%Excellent 28.68% Excellent | 29.93%Excellent 29.93% Excellent | 0.29Excellent 0.3 Excellent | 37.02%Excellent 37.02% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2469.60₹2470 | ₹105053.91₹105053.91 | 52.29Average 52.3 Average | 13.12%Average 13.12% Average | 13.50%Average 13.50% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 41/100 | ₹1148.10₹1148 | ₹102660.46₹102660.46 | 25.62Average 25.6 Average | 11.22%Average 11.22% Average | 13.04%Average 13.04% Average | 0.20Excellent 0.2 Excellent | 15.44%Excellent 15.44% Excellent | 12.09%Good 12.09% Good | 0.65% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1580.20₹1580 | ₹90035.87₹90035.87 | 25.38Average 25.4 Average | 10.06%Average 10.06% Average | 12.80%Average 12.80% Average | 0.21Excellent 0.2 Excellent | 0.80%Average 0.80% Average | 6.32%Good 6.32% Good | 0.26% |
Laurus Labs LtdLaurus Labs Ltd... LAURUSLABS • 540222 | 34.1/100 | ₹1816.20₹1816 | ₹84016.75₹84016.75 | 93.94Average 93.9 Average | 18.30%Good 18.30% Good | 17.76%Good 17.76% Good | 0.48Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price468821.49 Cr
- Divis Laboratories Ltd share price193163.97 Cr
- Torrent Pharmaceuticals Ltd share price169902.02 Cr
- Cipla Ltd share price116131.81 Cr
- Zydus Lifesciences Ltd share price115375.77 Cr
Tyche Industries Ltd PE Ratio History
Historical price-to-earnings ratio for TYCHE — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹17.80 | ₹191.05 | 10.7x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Tyche Industries Ltd Dividend History
Annual cash dividends paid by TYCHE — dividend yield 2.28%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹2.56 Cr |
| FY 2024 | ₹2.05 Cr |
| FY 2023 | ₹1.54 Cr |
| FY 2022 | ₹1.02 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Tyche Industries Ltd Quarterly Performance
Latest quarterly metrics for TYCHE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
30.96%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
22.34%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-7.28%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-19.65%
Compounded annual net profit growth over 5 years
Tyche Industries Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for TYCHE — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Tyche Industries Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Tyche Industries Ltd (TYCHE) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Tyche Industries Ltd
About TYCHE (Tyche Industries Ltd)
Tyche Industries Ltd is a dynamic pharmaceutical entity operating on a global scale, specializing in the intricate development and production of critical pharmaceutical components.... The company's core competencies lie in the synthesis and distribution of high-quality Active Pharmaceutical Ingredients (APIs) and vital pharmaceutical intermediates. Beyond these essential elements, Tyche demonstrates a strong commitment to innovation, venturing into the creation of specialized chiral intermediates and the development of advanced nutraceutical products. This multifaceted approach positions TYCHE as a comprehensive provider for companies requiring diverse and specialized pharmaceutical inputs. Furthermore, TYCHE extends its expertise through comprehensive contract service offerings, providing end-to-end support to its partners. These services encompass drug substance development, rigorous analytical testing, and complete contract development and manufacturing (CDMO) solutions. This comprehensive suite of services allows client companies to leverage TYCHE's advanced facilities and seasoned experts to accelerate drug development and streamline the manufacturing process, from initial concept to final product. Its commitment to quality and scientific rigor has allowed the organization to build a solid reputation within the global pharmaceutical market. Strategically headquartered in Hyderabad, India, TYCHE leverages its advantageous location to effectively serve key international markets. While maintaining a significant presence within India, the company's reach extends predominantly to the discerning pharmaceutical sectors of the United States and Europe. TYCHE's strategic export focus underlines its dedication to meeting the stringent quality standards and regulatory requirements of these key regions. Since its inception in 1998, TYCHE has steadily grown, establishing itself as a reliable and trusted partner for pharmaceutical companies worldwide, providing essential components and invaluable services.
Company Details
Key Leadership
Corporate Events
Latest News
TYCHE Share Price: Frequently Asked Questions
What is the current share price of Tyche Industries Ltd?
Tyche Industries Ltd (TYCHE) trades at ₹124.10 on NSE and BSE. Market cap ₹134.89 (Cr). Educational data only.
What is the P/E ratio of Tyche Industries Ltd?
Tyche Industries Ltd has a P/E of 19.44x vs industry average 34.89x.
What is the Bull Run score for Tyche Industries Ltd?
Tyche Industries Ltd has a Bull Run score of 45.1/100 based on 25+ financial parameters.
Does Tyche Industries Ltd pay dividends?
Tyche Industries Ltd has a dividend yield of 2.28%. Past dividends don't guarantee future payments.
What is the ROE of Tyche Industries Ltd?
Tyche Industries Ltd has ROE of 5.01%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Tyche Industries Ltd?
Tyche Industries Ltd has debt-to-equity of 0.00.
Is Tyche Industries Ltd a good investment?
Bull Run gives Tyche Industries Ltd a score of 45.1/100. This is not investment advice — consult a SEBI-registered advisor.